AtriCure, Inc. (ATRC) vs Azenta, Inc. (AZTA)
- AtriCure, Inc. ATRC 56.09 −2.92%
- Azenta, Inc. AZTA 34.09 −6.65%
AtriCure, Inc. and Azenta, Inc. are both Medical Instruments & Supplies companies. AtriCure, Inc. is the larger, with a market value of $2.9B against $1.6B — 1.8× the size. Azenta, Inc. has negative trailing earnings, so its P/E is not meaningful; AtriCure, Inc. trades at 259×. AtriCure, Inc. grew revenue faster over the last twelve months: 13.9% against 4.80%. AtriCure, Inc. has the higher net margin (1.85% vs −20.0%) and the higher return on invested capital (1.92% vs −9.27%). Across the 20 metrics below, AtriCure, Inc. leads on 14 and Azenta, Inc. on 6.
Valuation
Profitability
| Metric | ATRC | AZTA | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.30% | 44.05% | 54.29% |
| Operating margin | 2.26% | (28.56%) | 1.07% |
| Net margin | 1.85% | (20.02%) | (1.61%) |
| Free cash flow margin | 9.32% | 1.61% | 1.08% |
| Return on equity | 2.15% | (7.72%) | (1.32%) |
| Return on assets | 1.64% | (6.31%) | 0.00% |
| Return on invested capital | 1.92% | (9.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack